Cargando…

Database of adverse events associated with drugs and drug combinations

Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Poleksic, Aleksandar, Xie, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934730/
https://www.ncbi.nlm.nih.gov/pubmed/31882773
http://dx.doi.org/10.1038/s41598-019-56525-5
_version_ 1783483451453734912
author Poleksic, Aleksandar
Xie, Lei
author_facet Poleksic, Aleksandar
Xie, Lei
author_sort Poleksic, Aleksandar
collection PubMed
description Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA’s postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature.
format Online
Article
Text
id pubmed-6934730
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69347302019-12-30 Database of adverse events associated with drugs and drug combinations Poleksic, Aleksandar Xie, Lei Sci Rep Article Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA’s postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature. Nature Publishing Group UK 2019-12-27 /pmc/articles/PMC6934730/ /pubmed/31882773 http://dx.doi.org/10.1038/s41598-019-56525-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Poleksic, Aleksandar
Xie, Lei
Database of adverse events associated with drugs and drug combinations
title Database of adverse events associated with drugs and drug combinations
title_full Database of adverse events associated with drugs and drug combinations
title_fullStr Database of adverse events associated with drugs and drug combinations
title_full_unstemmed Database of adverse events associated with drugs and drug combinations
title_short Database of adverse events associated with drugs and drug combinations
title_sort database of adverse events associated with drugs and drug combinations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934730/
https://www.ncbi.nlm.nih.gov/pubmed/31882773
http://dx.doi.org/10.1038/s41598-019-56525-5
work_keys_str_mv AT poleksicaleksandar databaseofadverseeventsassociatedwithdrugsanddrugcombinations
AT xielei databaseofadverseeventsassociatedwithdrugsanddrugcombinations